What The Geneva Foundation does

The Geneva Foundation is a 501(c)(3) nonprofit research organization founded in 1993 and headquartered in Tacoma, Washington, with operational offices in Bethesda, Maryland; Frederick, Maryland; and Fayetteville, North Carolina. The organization provides research administration, regulatory affairs, program management, staffing, and contracting services to support military-relevant medical research across 39 DoD installations, federal laboratories, and academic partner institutions worldwide. Geneva is a statutory nonprofit authorized under the FY2014 National Defense Authorization Act to facilitate partnerships between military investigators and public or private organizations, with the unique ability to proffer or gift intellectual property to the Federal government.

Geneva's core operational model consists of four major research programs: AREVA (wearable life support and trauma technologies), MIRROR (musculoskeletal injury research with 40+ active studies), REC3ON (combat casualty care research), and the USU-4D Bio3 Center for Biotechnology (bioprinting, organ-on-chip, on-demand blood). The organization manages $387M in annual grant funding flowing to Geneva-supported principal investigators and secured over $45M in direct funding in 2024. Geneva partners with 250+ sponsors and collaborators including federal agencies (DoD, NIH, HHS, VA, CDMRP, DARPA, BARDA), academic institutions (Johns Hopkins, Stanford, MIT, Mayo Clinic, Thomas Jefferson), and industry players (Mapp Biopharmaceutical, Island Pharmaceuticals, Maquet Getinge, Fresenius).

Geneva generates revenue through federal research grants and contracts, industry-sponsored clinical trial management, GSA Schedule government contracting services, and donor philanthropy via the Discovery Fund. The organization operates on a break-even nonprofit basis with no profit assessed on grant awards; indirect cost rates are authorized by the Office of Naval Research. Customer concentration is overwhelmingly federal, with the U.S. Department of Defense and Military Health System as the primary client base. Distribution is achieved through embedded personnel at military treatment facilities and federal labs, with the H2F System teaming contract (awarded to Serco Inc. at $247M) representing a major recent commercial channel.

Name

The Geneva Foundation

Legal name

The Geneva Foundation

Website

https://genevausa.org

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

251–500 employees

Short description

The Geneva Foundation is a 501(c)(3) nonprofit research organization that provides research administration, program management, and contracting services to advance military medical research across 39 DoD installations and federal laboratories, partnering with 250+ government, academic, and industry sponsors.

Ownership category

akta.pro rank

Product category

Military medical research administration

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Defense R&D, Test, Evaluation & Innovation (BPAIAHAC)

akta.pro secondary industries

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Research & Science Grantmaking Foundations (BPAGAKAI), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Military medical research
• Clinical trial administration
• Federal research contracting
• Biodefense research
• Combat casualty care

Headquarters

HQ city

Tacoma

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Federal Research Grants and Contracts: Geneva secures and manages federal awards from DoD, NIH, HHS, VA, CDMRP, and other agencies. The organization recovers award management expenses through approved indirect cost rates authorized by the Office of Naval Research. Geneva operates on a break-even basis without assessing fees or profit on grant awards.
2. Industry Sponsorship and Clinical Trial Management: Geneva acts as intermediary between industry sponsors and military physicians, facilitating clinical trials. Military physicians cannot contractually obligate or receive direct payment for clinical trials, so Geneva submits research proposals on their behalf and collaborates with sponsors on agreement terms. Geneva recruits and manages dedicated study coordinators, regulatory specialists, and contract personnel.
3. Government Contracting: Geneva holds a GSA Schedule under the Multiple Award Schedule (MAS), streamlining federal customer service delivery. Services include staffing, program management, regulatory affairs, and research operations support for federal agencies.
4. Philanthropy and Donor Contributions: Geneva accepts tax-deductible donations as a 501(c)(3) nonprofit. Donors can contribute to the Discovery Fund to support follow-on research, pilot studies, new researcher empowerment, and urgent challenges.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The Geneva Foundation is a 501(c)(3) nonprofit research organization that administers and manages military medical research on behalf of DoD investigators and federal agencies. It secures and manages federal grants and contracts from DoD, NIH, HHS, VA, and CDMRP; facilitates industry-sponsored clinical trials by acting as the contractual intermediary for military physicians; and deploys dedicated research personnel across 39 DoD installations and federal laboratories. Its program portfolio includes AREVA (critical care/portable ECMO), MIRROR (musculoskeletal injury research), REC3ON (combat casualty care), and the USU-4D Bio3 Center for Biotechnology.

Product overview

The Geneva Foundation is a nonprofit research organization that advances military medical research through multiple specialized programs and service offerings. The core portfolio includes AREVA (critical care and extracorporeal life support technologies), MIRROR (musculoskeletal injury rehabilitation research), REC3ON (combat casualty care research), and the USU-4D Bio3 Center for Biotechnology (bioprinting and advanced biotech). These programs are supported by foundational services including research administration, regulatory affairs, government contracting, data management, staffing, education and training, commercialization support, and research dissemination. The organization operates as a strategic convener connecting government, academia, industry, and research teams to deliver mission-ready medical solutions.

Differentiator

Problem solved

Functional benefit

Brands

• AREVA (Autonomous Reanimation and Evacuation Research Institute & Innovation Center): Program advancing wearable medical technologies, polytrauma management, and critical care solutions tailored to combat and austere environments.
• MIRROR (Musculoskeletal Injury Rehabilitation Research for Operational Readiness)
• REC3ON (Research for Combat Casualty Care Operations Network)
• Fort Liberty Research Institute
• 4D Bio3 Center for Biotechnology
• Wave the Flag Award

Products and services

• AREVA (Autonomous Reanimation and Evacuation Research Institute & Innovation Center) Research program advancing wearable medical technologies, polytrauma management, and critical care solutions tailored to combat and austere environments; develops portable extracorporeal life support (ECLS/ECMO) systems, heparin-free systems, and autonomous critical care technologies. For military investigators, federal agencies, and industry collaborators.
• MIRROR (Musculoskeletal Injury Rehabilitation Research for Operational Readiness) Research program providing critical infrastructure and operational support for transforming treatment and preventive care of musculoskeletal injuries (MSKI) within the Military Health System, managing over 40 studies. For military investigators and federal agencies.
• REC3ON (Research for Combat Casualty Care Operations Network) Research program advancing combat casualty care through research in hemorrhage control, battlefield resuscitation, and innovative treatment technologies. Based at Madigan Army Medical Center with active duty, reservist, and staff surgeons. For military investigators and federal agencies.
• USU-4D Bio3 Center for Biotechnology Center developing and adapting biotechnology to benefit warfighter readiness and resilience; focuses on biofabrication, tissue engineering, organ-on-chip, on-demand blood production, and bioprinting for austere military environments. For military investigators and federal agencies.
• Fort Liberty Research Institute Research institute conducting mission-focused research in human performance, sustainment, and traumatic brain injury to support warfighter readiness and resilience. For military investigators and federal agencies.
• Research & Development Services Comprehensive research administration including program development & management, regulatory affairs, research operations, and collaborations & partnerships support. For DoD research sites, federal agencies, and military investigators.
• Government Contracting Services Contract vehicles, key capabilities, corporate experience & past performance, and partnerships & alliances for federal agencies. Includes GSA Schedule (MAS) for streamlined procurement.
• Data Management Data management solutions driving innovation and decision making for military medical research programs.
• Staffing Services Recruiting and managing highly qualified personnel (study coordinators, regulatory specialists, contract personnel) for military research facilities.

Quantifiable outcome

• More than 400 research programs supported across military treatment facilities, federal laboratories, and academic institutions worldwide
• +5 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

34 partnerships are on record, tiered core and major.

• U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)coreStrategic or Co-development Partner · 3 March 2026Three-year CRADA with Island Pharmaceuticals and USAMRIID to advance Galidesivir for Marburg Virus Disease under FDA Animal Rule pathway with non-human primate studies toward NDA submission.
• U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)coreStrategic or Co-development Partner · 1 January 2024Geneva supports USAMRIID researchers including Dr. Kathleen Cashman (Lassa fever vaccine development) and Dr. Sandra Bixler (Marburg virus monoclonal antibody testing). Partnership advancing infectious disease countermeasures for military readiness and global health security.
• Serco Inc.coreChannel Partner/ Reseller/ DistributorGeneva serves as teaming partner on $247M U.S. Army Holistic Health and Fitness (H2F) System contract alongside HigherEchelon, Hyperion Biotechnology, and Resolution Think to enhance Soldier readiness and performance.
• VA Puget Sound Health Care SystemcoreStrategic or Co-development PartnerLong-standing partnership providing expert staffing for the Animal Research Facility enabling biomedical research that improves therapies, rehabilitation, and care standards for veterans.
• Uniformed Services University (USU)coreStrategic or Co-development PartnerCooperative agreement with USU for MIRROR program (musculoskeletal injury research) and 4D Bio3 Center for Biotechnology. Partnership since 2016 MOU expanded in 2017 and 2019 to include TriService Nursing Research Program.
• Medical Technology Enterprise Consortium (MTEC)coreStrategic or Co-development PartnerPartnership for medical technology research including Ukraine trauma database project, SurgNow 3D-printed surgical instruments, and other advanced medical technology initiatives.
• Mapp Biopharmaceutical, Inc.coreStrategic or Co-development PartnerPartnership for efficacy testing of MBP091 monoclonal antibody against Marburg virus in nonhuman primate model, advancing life-saving countermeasures for highly lethal Marburg virus disease.
• Island PharmaceuticalscoreStrategic or Co-development PartnerThree-year CRADA partnership to advance Galidesivir antiviral for Marburg Virus Disease under FDA Animal Rule pathway, with goal of NDA submission and potential US government procurement and Priority Review Voucher.
• Thomas Jefferson UniversitycoreStrategic or Co-development PartnerAcademic partnership co-leading Lassa fever vaccine (LASSARAB) development with $30M NIH grant, using deactivated rabies virus platform demonstrating strong protection in preclinical trials.
• University of Maryland, BaltimorecoreStrategic or Co-development PartnerAcademic partnership in Lassa fever vaccine research alongside Thomas Jefferson University and USAMRIID, advancing LASSARAB vaccine candidate to Phase 1 clinical trial.
• BARDAcoreStrategic or Co-development PartnerPartnership through AREVA Network for advanced development of Multiorgan Extracorporeal Life Support (MELS) system, a portable heparin-free ECMO platform.
• DraegermajorTechnology or IntegrationAREVA Network partner for extracorporeal life support technology development and integration.
• Draper LabsmajorTechnology or IntegrationAREVA Network partner for advanced life support technology development.
• Fresenius Medical CaremajorTechnology or IntegrationAREVA Network partner for renal support integration in portable ECMO systems.
• KBR LaboratoriesmajorTechnology or IntegrationAREVA Network partner for life support technology development.
• Maquet Getinge GroupmajorTechnology or IntegrationAREVA Network partner for extracorporeal membrane oxygenation technology.
• Mayo CliniccoreStrategic or Co-development PartnerAREVA Network partner for clinical translation of life support technologies.
• Thornhill MedicalmajorTechnology or IntegrationAREVA Network partner for integrated life support solutions.
• Critical Innovations, LLCmajorStrategic or Co-development PartnerPartnership for Revite Automated Trauma Resuscitation System (DARPA-funded) and SurgNow 3D-printed surgical instruments (MTEC-funded) for austere environments.
• Congressionally Directed Medical Research Programs (CDMRP)coreStrategic or Co-development PartnerFederal funding partner for multiple research initiatives including musculoskeletal injury studies and warfighter recovery projects.
• Defense Advanced Research Projects Agency (DARPA)coreStrategic or Co-development PartnerFederal research partner for Revite trauma system, On-Demand Blood program (derived from Blood Pharming), and GOLDen hour extended EVACuation (GOLDEVAC) efforts.
• National Institutes of Health (NIH)coreStrategic or Co-development PartnerFederal partner supporting Lassa fever vaccine research ($30M grant) and other biomedical research initiatives.
• U.S. Department of Veterans Affairs (VA)coreStrategic or Co-development PartnerFederal partner for veteran-focused innovation through VA Puget Sound and other VA facilities supporting animal research and biomedical research.
• Madigan Army Medical CentercoreStrategic or Co-development PartnerHost site for REC3ON program advancing combat casualty care through research in hemorrhage control, battlefield resuscitation, and innovative treatment technologies.
• National Heart, Lung, and Blood Institute (NHLBI)coreStrategic or Co-development PartnerFederal research partner for blood products and transfusion research including transfusable low-titer Type O whole blood development.
• U.S. Air Force 59th Medical WingcoreStrategic or Co-development PartnerFederal partner funding REC3ON research on Negative Pressure Wound Therapy and supporting VAPOR validated assessment program for medical technology readiness.
• The Henry M. Jackson Foundation for the Advancement of Military MedicinemajorStrategic or Co-development PartnerNonprofit partner in the military medical research ecosystem with shared mission to advance military medicine.
• University of IowamajorStrategic or Co-development PartnerAcademic partner with Dr. Yang Liu for Digital Dental Loupes (Loupes 2.0) project optimizing military dental and maxillofacial care in austere environments.
• Unify MedicalmajorTechnology or IntegrationIndustry partner for Loupes 2.0 digital dental loupes development in collaboration with University of Iowa.
• SeaStar MedicalmajorStrategic or Co-development PartnerDoD award through AREVA to evaluate SeaStar Medical's SCD therapy for advancing breakthrough burn and sepsis research.
• Armed Forces Research Institute of Medical Sciences (AFRIMS)coreStrategic or Co-development PartnerInternational research site in Bangkok supporting malaria vaccine and infectious disease research with global partners since 2007.
• Johns Hopkins UniversitycoreStrategic or Co-development PartnerAcademic research partner with active collaborations across multiple research programs.
• Stanford UniversitycoreStrategic or Co-development PartnerAcademic research partner with active collaborations across multiple research programs.
• Massachusetts Institute of Technology (MIT)coreStrategic or Co-development PartnerAcademic research partner with active collaborations across multiple research programs.

Scale indicators11 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• The Henry M. Jackson Foundation for the Advancement of Military Medicine: Largest and most direct peer nonprofit supporting military medical research, administering hundreds of millions in DoD research funding with a similar intermediary model connecting military investigators, federal agencies, and industry partners.
• MRIGlobal: Nonprofit scientific research organization performing applied research in defense, health, and CBRNE for government clients; comparable in mission and federal contracting posture, though broader in scope beyond military medicine.
• Westat: Employee-owned research firm providing statistical, health, and clinical research services for federal agencies including HHS and DoD, with comparable government contracting posture.
• Infectious Disease Research Institute (IDRI, now AAHI): Nonprofit biotech developing vaccines and immune therapies for infectious diseases with significant DoD and global health funding overlap, particularly relevant to Geneva's infectious disease portfolio.

Broad incumbents

• Battelle Memorial Institute: Large nonprofit applied science and research organization with substantial defense and biomedical portfolios; operates at significantly greater scale and broader scope but comparable in nonprofit contract research model.
• RTI International: Nonprofit research institute performing health, defense, and applied research for government and commercial clients with similar contract and grant administration infrastructure.
• MITRE Corporation: Federally funded research and development center (FFRDC) operator providing research and systems engineering to defense and health agencies; comparable in mission-driven research model though broader in scope.
• Science Applications International Corporation (SAIC): Large federal contractor with a substantial defense health and medical research portfolio, providing technical and program management services to DoD and federal health agencies.

Others

• National Marrow Donor Program / Be The Match: Nonprofit operating federally funded research and clinical programs with similar C-suite, board, and federal contracting structure, including relationships with DoD and NIH.

Emerging players

• American Type Culture Collection (ATCC): Nonprofit biological resource and research organization supporting government, academic, and industry research with comparable R&D services and federal sponsor relationships in life sciences.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/the-geneva-foundation
• Xx.com/genevaUSA

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Geneva Foundation